| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K24690302 |
| PharmacoGx | BRD-K24690302 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZNF22 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | FLT3 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | SLCO2B1 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | TAF5L | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | SLC25A48 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | TXNDC9 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | FEM1B | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | IGFALS | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | NRSN2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | TOR2A | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
